BIT's 2nd International Biotechnology Congress-2018 (IBC-2018)

BIT's 2nd International Biotechnology Congress-2018 (IBC-2018), with the theme of “From Innovation to Applications” will be held during October 14-16, 2018 at Fukuoka, Japan.

This unique international conference creates a great platform to researches, scientists, academicians and industry experts to share experiences, discuss research findings and acquire the desired knowledge for practical exercise. IBC-2018 is a dedicated event where you will have the opportunity to learn about new developments in the field of Biotechnology, Gene and Life Sciences, and share aspects of your own work by submitting a poster or oral presentation. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better practice and application. We hope your participation would contribute to your professional development and relationships.

Wish you enjoy the conference!

Program at a Glance
Opening Ceremony
& Keynote Forum
Keynote Speakers of IBC-2018
Dr. Tim Hunt
Emeritus Group Leader
Clare Hall Laboratories

Nobel Prize laureate in Physiology or Medicine, 2001
Dr. Behzad Mahdavi
VP Strategic Innovation & Alliances
Lonza Walkersville, Inc.
Dr. Reiko Kuroda
Tokyo University of Science

Sir Richard Timothy Hunt, FRS FMedSci FRSE (born 19 February 1943) is a British biochemist and molecular physiologist. He was awarded the 2001 Nobel Prize in Physiology or Medicine with Paul Nurse and Leland H. Hartwell for their discoveries of protein molecules that control the division of cells. In particular, Hunt discovered what he called cyclin: a protein in fertilised sea urchin eggs which cyclically aggregates and is depleted during cell division cycles. Following his PhD, Hunt returned to New York to work with London, in collaboration with Nechama Kosower, her husband Edward Kosower, and Ellie Ehrenfeld. While there, they discovered that tiny amounts of glutathione inhibited protein synthesis in reticulocytes and that tiny amounts of RNA killed the synthesis altogether. After returning to Cambridge, he again began work with Tony Hunter and Richard Jackson, who had discovered the RNA strand used to start haemoglobin synthesis. After 3–4 years, the team discovered at least two other chemicals acting as inhibitors.Hunt was elected a member of the European Molecular Biology Organization (EMBO) in 1978, serving as a member of the organisation's Fellowship Committee 1990–1993, its Meeting Committee 2008–2009, and its governing body, the Council, 2004–2009. He was elected a Fellow of the Royal Society (FRS) in 1991.

Behzad Mahdavi is serving as Vice President of Strategic Innovation & Alliances at Lonza, one of the world's leading suppliers to the Pharma&Biotech and Specialty Ingredient markets, as a Chairman of the Board of Exosomics, an innovator leader in the field of Liquid Biospy and as a member of Investment and Advisory committee for C3E Venture Capital Fund, one of the most active private fund in Canada. He began in his current position at Lonza in 2010 after three years serving as Head of Lonza Canada. Prior to joining Lonza, he was CEO of SAM Electron Technologies, a venture capital-backed company in the Life Sciences field, which was acquired in 2007 by a multinational company. During his entire career, Behzad worked for several private organizations, governmental companies and venture capital firms in different capacities as senior executive, advisor, CEO and board member.  In these roles, he was involved in leading, managing and advising technological start-ups/companies in fund raising, strategic business development, efficient innovation management and commercialization/spinoff to create new profitable growth axis. He earned his MBA from the University of Quebec in Montreal, Canada, his Ph.D. in Chemistry from University of Sherbrooke, Canada, his M.S. in Industrial Chemicals & Environment from the University of Rennes, France and his B.Sc. in Chemical Engineering from ENSCR, France.

Dr. Reiko Kuroda, Professor at Research Institute for Science and Technology at Tokyo University of Science/ Professor Emeritus at The University of Tokyo, has obtained Ph.D. in Chemistry from The University of Tokyo. She worked at King’s College London in the Department of Chemistry and then Biophysics, as well as at Institute of Cancer Research, UK. Returned to Japan as an Associate Professor, and became a full professor in 1992, the first female full professor in the field of natural sciences at the University of Tokyo. She is a chemist as well as biologist and her main research interest is chiromorphology. In addition to her scientific activity, she is involved in science policy, higher education policy, science communication and promotion of STEM career especially for women/girls. L’Oreal UNESCO Women in Science Award (2013), Vice president of ICSU (International Council for Science, 2008-11), Scientific Advisory Board to the UN Secretary General (2013-16) etc.In Japan, member of Council of Science and Technology Policy (2001-7), and Ambassador of WINDS (Women’s Initiative in Developing STEM Career) (2016- ). She is a member of the Royal Swedish Academy of Sciences.

Renowned Speakers of IBC-2017
Dr. Alexei A. Kornyshev
Imperial College London
Dr. Xiang Zhang
Lucideon & University of Cambridge
Dr. Charlie Zhang
Dr. Takao Ito
Merck Life Sciences
Dr. Hari Sunkara
DuPont Industrial Biosciences
Dr. Zhijian Liu
Merck Sharp & Dohme Corp
Dr. Jae Kwang Park
University of Wisconsin-Madison
Dr. Yong Xu
University of Kentucky
Dr. Ze-Chun Yuan
University of Western Ontario
Dr. Jim Davidson
Dr. Christiane Zell
Offenburg University
Dr. Giulio Filippo Tarro
Foundation de Beaumont Bonelli for Cancer Research
Dr. Hajime Hirao
City University of Hong Kong
Hong Kong, China
Dr. Mel Luetkens
Consulting Services
Dr. K. Jim Jem
Total Corbion PLA Ltd.
Dr. Yucheng Zhou
Novozymes (China) Investment Co. Ltd.
Dr. Linqiu Cao
Royal FrieslandCampina
The Netherlands
Dr. Zhonghua Sun
Curtin University
Dr. Pao Chi Chen
Lunghwa University of Science and Technology
Dr. Huaning Yu
Bright Dairy & Food Co., Ltd.
Dr. Peng-Sheng Wei
National Sun Yat-Sen University
Dr. Jun Zhu
LivingZone (Shanghai) Bio-Chem Technology
Dr. Zhenyi Zhang
Tsinghua University
Dr. Heidi M. Steinhauer
Embry-Riddle Aeronautical University
Dr. Fanny Liao
Far Eastern New Century Corporation
Dr. Sae-Eun Oh
Hanbat National University
South Korea
Dr. Shengyong Xu
Peking University
Dr. Dongxiao Zhu
Wayne State University
Dr. Koon-Yang Lee
Imperial College London
Dr. Hong Liang
Zhongkai University of Agriculture and Engineering
Dr. Dahl-Young Khang
Yonsei University
South Korea
Dr. Bernd Pickert
Eggersmann Anlagenbau GmbH
Dr. Wei Min Huang
Nanyang Technological University
Dr. Franz E. Weber
University of Zurich
Mr. David O’Connor
Lachman Consultants
Dr. Patrick van Rijn
University Medical Center Groningen
The Netherlands
Previous Event Report
Exhibition and Sponsorship

As part of the IBC-2018, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of biotechnology. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.

Exhibitors' Advantages
• The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for longer discussion with inquiring visitors - in most cases specialists - than during session discussions. More>>

IBC-2018 is one of the most effective international marketing platforms in the field of biotechnology and life science, which offers a wide range of sponsoring categories for branding and highlighting your company in order to achieve the best publicity. More>>

Introduction to Fukuoka

Fukuoka is the capital city of Fukuoka Prefecture, situated on the northern shore of the Japanese island of Kyushu. It is the most populous city on the island, followed by Kitakyushu. It is the largest city and metropolitan area west of Keihanshin. The city was designated on April 1, 1972, by government ordinance. Greater Fukuoka, with 2.5 million people (2005 census), is part of the heavily industrialized Fukuoka–Kitakyushu zone as well as Northern Kyushu.As of 2015, Fukuoka is Japan’s fifth largest city, having passed the population of Kobe. As of July 2011, Fukuoka passed the population of Kyoto. Since the founding of Kyoto in 794, this marks the first time that a city west of the Kinki region has a larger population than Kyoto. In ancient times, however, the area near Fukuoka, the Chikushi region, was thought by some historians to have possibly been even more influential than the Yamato region.

News Released

Speaking proposals are now being accepted, download the Format of Abstract and CV
Call for Exhibitors and Sponsors
Call for Collaborative Partners, Media and Journals

Hosting Organization
World High Technology Society (WHTS)
Operating Organization
Official Travel Agency
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2017-2018 BIT Congress Inc.